JP Morgan analyst Julia Qin downgrades Invitae (NYSE:NVTA) from Neutral to Underweight.
Microbot Medical Announces $2.35M Registered Direct Offering Of 1,566,669 Shares Of Common Stock At A Price Of $1.50 Per Share
Microbot Medical Inc. (NASDAQ:MBOT) today announced that it has entered into definitive agreements for the purchase and sale of 1,566,669 shares of the Company's common stock at a purchase price of $1.50 per share of
